Skip to main content

Alzheimer's Disease, Dementia & Cognitive Disorders

In this video, geriatric psychiatrist Marc E. Agronin, MD, discusses medications that may improve cognition in patients with Alzheimer's disease.
A blood test measuring phospho-tau217 (p-tau217), a major component of Alzheimer’s disease-related tau tangles, was able to discriminate participants with Alzheimer’s disease from those with other neurodegenerative diseases.
Adults aged 40 years and older who reported a history of repetitive head impact had more symptoms of depression and difficulties in cognitive functioning, compared with those without such a history, according to a study in Neurology.
The US Food and Drug Administration (FDA) has approved Tauvid (flortaucipir F18) for intravenous injection in adults with cognitive impairment who are being evaluated for Alzheimer’s disease.
Virtual reality technology may one day replace traditional pencil-and-paper activities for cognitive training in older adults, suggests a study published online in the International Journal of Geriatric Psychiatry.
Consuming more food and drink with the antioxidant flavonol is associated with a smaller chance of developing Alzheimer’s dementia years later, researchers reported in Neurology.
Back to Top